Importer of Controlled Substances Registration, 2571 [2019-01521]

Download as PDF 2571 Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices Drug code Controlled substance Beta-hydroxythiofentanyl ......................................................................................................................................................... N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .................................................................................. Amphetamine ........................................................................................................................................................................... Methamphetamine ................................................................................................................................................................... Codeine ................................................................................................................................................................................... Dihydrocodeine ........................................................................................................................................................................ Oxycodone ............................................................................................................................................................................... Hydromorphone ....................................................................................................................................................................... Hydrocodone ........................................................................................................................................................................... Isomethadone .......................................................................................................................................................................... Methadone ............................................................................................................................................................................... Methadone intermediate .......................................................................................................................................................... Morphine .................................................................................................................................................................................. Thebaine .................................................................................................................................................................................. Levo-alphacetylmethadol ......................................................................................................................................................... Oxymorphone .......................................................................................................................................................................... Thiafentanil .............................................................................................................................................................................. Alfentanil .................................................................................................................................................................................. Sufentanil ................................................................................................................................................................................. Carfentanil ............................................................................................................................................................................... Fentanyl ................................................................................................................................................................................... The company plans to manufacture the listed controlled substances to make reference standards which will be distributed to their customers. Dated: December 21, 2018. John J. Martin, Assistant Administrator. DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration [FR Doc. 2019–01510 Filed 2–6–19; 8:45 am] ACTION: Notice of registration. BILLING CODE 4410–09–P The registrant listed below has applied for and been granted a SUMMARY: FR Docket Sigma Aldrich Co., LLC ................................................................................................................................. 83 FR 60903 VerDate Sep<11>2014 17:23 Feb 06, 2019 Jkt 247001 Dated: January 3, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–01521 Filed 2–6–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Research Triangle Institute ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 11, 2019. Such persons may also file a written request for a DATES: PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 I I II II II II II II II II II II II II II II II II II II II registration by the Drug Enforcement Administration (DEA) as an importer of schedule I and II controlled substances. SUPPLEMENTARY INFORMATION: The company listed below applied to be registered as an importer of various basic classes of controlled substances. Information on the previously published notice is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for this notice. Company The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrant to import the applicable basic classes of schedule I and II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security system, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I and II controlled substances to the above listed company. 9836 9843 1100 1105 9050 9120 9143 9150 9193 9226 9250 9254 9300 9333 9648 9652 9729 9737 9740 9743 9801 Schedule Published November 27, 2018. hearing on the application on or before March 11, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to E:\FR\FM\07FEN1.SGM 07FEN1

Agencies

[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Page 2571]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01521]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrant listed below has applied for and been granted a 
registration by the Drug Enforcement Administration (DEA) as an 
importer of schedule I and II controlled substances.

SUPPLEMENTARY INFORMATION: The company listed below applied to be 
registered as an importer of various basic classes of controlled 
substances. Information on the previously published notice is listed in 
the table below. No comments or objections were submitted and no 
requests for hearing were submitted for this notice.

----------------------------------------------------------------------------------------------------------------
                 Company                             FR Docket                           Published
----------------------------------------------------------------------------------------------------------------
Sigma Aldrich Co., LLC...................  83 FR 60903                    November 27, 2018.
----------------------------------------------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrant to 
import the applicable basic classes of schedule I and II controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security system, verifying the company's 
compliance with state and local laws, and reviewing the company's 
background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I and II controlled substances to the above 
listed company.

    Dated: January 3, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01521 Filed 2-6-19; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.